Skip to main content
. 2007 May 15;91(10):1303–1307. doi: 10.1136/bjo.2007.116939

Table 1 Demographic and clinical characteristics of study sample.

Characteristics NV‐AMD (n = 75) Control (n = 91)
Age, years
 Mean (SD) 79.6 (6.43) 65.3 (8.53)
 Median 80 65
 Range 60–92 50–86
Gender, n (%)
 Male 28 (37.3) 46 (50.5)
 Female 47 (62.7) 45 (49.5)
Race, n (%)
 Caucasian 75 (100) 76 (83.5)
 Black 0 (0) 1 (1.1)
 Asian 0 (0) 4 (4.4)
 Other 0 (0) 7 (7.7)
 Missing 0 (0) 3 (3.3)
Living situation in the past 12 months, n (%)
 Living with spouse or family member 46 (61.3) 71 (78.0)
 Living alone 26 (34.7) 19 (20.9)
 Living in assisted living facility or nursing home 3 (4.0) 1 (1.1)
Current best‐corrected visual acuity in better‐seeing eye
 Mean (SD) 0.26 (0.19) 0.91 (0.24)
 Median 0.17 1.0
 Range 0.04–0.67 0.50–1.5
Co‐morbid diseases, n (%)*,†
 Cataract 14 (18.7) 6 (6.6)
 Glaucoma 3 (4.0) 0 (0.0)
 Headache 0 (0.0) 5 (5.5)
 Anxiety disorder 0 (0.0) 8 (8.8)
 Asthma 1 (1.3) 9 (9.9)
 Chronic neck/back pain 3 (4.0) 12 (13.2)

NV‐AMD = neovascular age‐related macular degeneration; SD = standard deviation.

*Categories are not mutually exclusive. †Not all co‐morbid diseases assessed are listed. Differences between study groups are statistically significant (p<0.05) for all listed co‐morbidities. Other co‐morbid diseases assessed included depression, diabetes, chronic obstructive pulmonary disease, arthritis, heart disease, stroke and sleep disturbance.